MUSC Hollings Cancer Center Researchers Shikhar Mehrotra, Ph.D., and Besim Ogretmen, Ph.D. (IMAGE)
Caption
Dr. Shikhar Mehrotra (left) and Dr.Besim Ogretmen (right) co-founded a company that is developing technology to enhance and improve the functionality of T cells in adoptive cell therapy.
Credit
MUSC Hollings Cancer Center
Usage Restrictions
permission to use with appropriate credit
License
Licensed content